Gel Documentation Systems Market

As per Market Research Future Analysis, the Global Gel Documentation Systems Market was valued at USD 0.35 Billion in 2023 and is projected to grow to USD 0.54 Billion by 2032, with a CAGR of 4.4% from 2024 to 2032. The market serves various sectors including hospitals, diagnostic laboratories, and research institutes, utilizing gel documentation systems for imaging nucleic acids and proteins. Key applications include protein quantification and immunoassays. The Americas are expected to dominate the market due to high R&D spending and technological advancements, followed by Europe and the Asia-Pacific region, which is anticipated to grow the fastest due to increased government focus on biotechnology.

Bio-Rad Laboratories, Inc.; Bio-Techne; Endress + Hauser Management AG; GE Healthcare; Thermo Fisher Scientific; LI-COR Biosciences; Vilber Lourmat; Scientific Digital Imaging Plc.; Cleaver Scientific; Azure Biosystems

A definitive business combination agreement has been reached between Gelesis, Inc., a biotherapeutics company developing biomimetic superabsorbent hydrogels to treat excess weight and metabolic disorders, and Capstar Special Purpose Acquisition Corp., a special purpose acquisition company sponsored by Capstar Partners, LLC affiliates and certain private funds managed by PIMCO. Gelesis hopes to revolutionize weight management with the successful beta launch of its first product, Plenity, which is developed using a unique biomimetic medicinal platform.

Researchers at the Universidad Carlos III de Madrid (UC3M) have created a system that uses computer vision techniques to analyze biomedical movies acquired by microscopy in order to characterize and describe the behavior of the cells shown in the images. These novel methods have been applied to measuring live tissues. As a result, the researchers observed that neutrophils immune cells exhibit several behaviors in the blood during inflammatory processes, one of which is linked to the development of cardiovascular disease and is induced by the Fgr protein.Intended Audience:

• Gel Documentation System Manufacturers and Distributors
• Pharmaceutical and Biotechnological Companies
• Contract Research Organizations
• Academic and Research Institutes
• Government Associations